Search Results

Containing any of the words

Only of the type

A randomized, sham-controlled, double-blind study to evaluate the efficacy and safety of intrathecal (IT) OAV101 in patients with later onset Type 2 spinal muscular atrophy (SMA) who are ≥ 2 to < 18 years of age, treatment naive, sitting, and never ambulatory Drug Clinical Trial

A H3N2 Avictoria 800 2024 CVR 289,A H1N1 A Georgia 12 2022 CVR 167,B Victoria Lineage B Singapore WUH4618 2021 New SFDA Drug Approvals

Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis Drug Clinical Trial

Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis Drug Clinical Trial

Ketoconazole and hepatotoxicity News

FDA Notifies Consumers that Tomatoes in Restaurants Linked to Salmonella Typhimurium Outbreak News

The SFDA Plans to Set a National Project to Monitor Residues of Pesticides and Chemical Pollutants in Food News

Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy Awareness Article

Information for Healthcare Professionals: OnabotulinumtoxinA (marketed as Botox/Botox Cosmetic), Awareness Article

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma Awareness Article